USA - engelsk - NLM (National Library of Medicine)

king bio inc. - anamirta cocculus seed (unii: 810258w28u) (anamirta cocculus seed - unii:810258w28u), colchicum autumnale bulb (unii: 993qhl78e6) (colchicum autumnale bulb - unii:993qhl78e6), gelsemium sempervirens root (unii: 639kr60q1q) (gelsemium sempervirens root - unii:639kr60q1q), juniper berry (unii: o84b5194rl) (juniper berry - unii:o84b5194rl), potassium carbonate (unii: bqn1b9b9ha) (carbonate ion - unii:7ujq5ope7d), potassium phosphate, dibasic (unii: ci71s98n1z) (phosphate ion - unii:nk08v8k8hr), strychnos - uses for temporary relief of: symptoms due to jet lag/shift change: fatigue, sleeplessness, irritability, nervous tension, spasmodic yawning, drowsiness. uses  for temporary relief of: symptoms due to jet lag/shift change: - fatigue - sleeplessness - irritability - nervous tension - spasmodic yawning - drowsiness

Canada - engelsk - Health Canada

avir pharma inc. - sincalide - powder for solution - 5mcg - sincalide 5mcg - gallbladder function

USA - engelsk - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - zinc acetate (unii: fm5526k07a) (zinc cation - unii:13s1s8sf37) - zinc cation 25 mg - zinc acetate therapy is indicated for maintenance treatment of patients with wilson’s disease who have been initially treated with a chelating agent (see precautions: monitoring patients). zinc acetate capsules are contraindicated in patients with known hypersensitivity to any of the components of the formulation.

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

value plus - biotin(180mg/kg) - oral powder, pre-mix - vitamin - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - hoof disorder | vitamin | biotin deficiencies | detoxifying agent | erythropoietic activity | stamina | vitamin a | vitamin b | vitamin c | vitamin d | vitamin deficiencies | vitamin e | vitamin k

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bell laboratories, inc. - zinc phosphide; malathion - ready-to-use bait - zinc phosphide ungrouped active 20.0 g/kg; malathion organophosphorus other 0.11 g /kg - vertebrate poison - canola - see label | grain crop | legume crop | nut crop | pasture - refer to label for use | safflower - refer to label - rodent, rat or mouse | black rat/mouse | brown rat/mouse | mouse | rat | rodent | roof rat

USA - engelsk - NLM (National Library of Medicine)

king bio inc. - hpus active ingredients, equal volumes of each ingredient in 6x, 30x, 6c, 30c, and lm1 potencies., arnica montana, arnica montana radix, reference image of arnica.jpg - hpus active ingredients purpose equal volumes of each ingredient in 6x, 30x, 6c, 30c, and lm1 potencies. arnica montana.......................................traumatic injury, sprains, bruises, body aches, muscle pain, inflammation arnica montana radix..............................redness and swelling, sensitivity to touch reference image of arnica.jpg uses temporarily relieves symptoms due to injury or overexertion: - bruises - muscle pain - inflammation - body aches - sprains - traumatic injury - redness and swelling - soreness after exercise - rheumatic pain as per various homeopathic materia medicas. king bio inc. 3 westside drive asheville, nc 28806 www.kingbio.com reference image of arnica.jpg

Den europeiske union - nederlandsk - EMA (European Medicines Agency)

biopartners gmbh - ribavirin - hepatitis c, chronisch - antivirale middelen voor systemisch gebruik - ribavirine biopartners is geïndiceerd voor de behandeling van chronische hepatitis-c-virus (hcv) infectie bij volwassenen, kinderen drie jaar en ouder en adolescenten en mag alleen worden gebruikt als onderdeel van een regime van de combinatie met interferon alfa-2b. monotherapie met ribavirine mag niet worden gebruikt. er is geen informatie over veiligheid of werkzaamheid over het gebruik van ribavirine met andere vormen van interferon (d.w.z.. niet alfa-2b). naïef patientsadult patientsribavirin biopartners is aangegeven, in combinatie met interferon-alfa-2b, voor de behandeling van volwassen patiënten met alle vormen van chronische hepatitis c met uitzondering van genotype 1, die niet eerder behandeld, zonder lever decompensation, met verhoogde alanine aminotransferase (alt), die positief zijn voor hepatitis c virale ribonucleïnezuur (hcv-rna) (zie sectie 4. 4)kinderen die de leeftijd van drie jaar en ouder en adolescentsribavirin biopartners is bedoeld voor gebruik in combinatie regime met interferon-alfa-2b, voor de behandeling van kinderen van drie jaar en ouder en adolescenten, die alle vormen van chronische hepatitis c met uitzondering van genotype 1, die niet eerder behandeld, zonder lever decompensation, en die positief zijn voor hcv-rna. bij de beslissing om niet aan het uitstellen van de behandeling tot aan de volwassen leeftijd, is het belangrijk om te overwegen dat de combinatie therapie geïnduceerde een groeiremming. de omkeerbaarheid van de groeiremming is onzeker. de beslissing om de behandeling moet worden gemaakt op een geval per geval (zie paragraaf 4. vorige-behandeling-niet patientsadult patientsribavirin biopartners is aangegeven, in combinatie met interferon-alfa-2b, voor de behandeling van volwassen patiënten met chronische hepatitis c die eerder hebben gereageerd (met een normalisatie van de alt-aan het einde van de behandeling) aan interferon alfa monotherapie, maar die later herviel (zie sectie 5.

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

norbrook laboratories australia pty limited - ampicillin as the sodium salt; cloxacillin as sodium monohydrate salt - misc. intra mammary - ampicillin as the sodium salt antibiotic active 75.0 mg/5gsyr; cloxacillin as sodium monohydrate salt antibiotic active 200.0 mg/5gsyr - antibiotic & related - dairy cattle lactating | bovine | milking cow - antibiotic - anti-infective | antibiotics - oral, parenteral | arcanobacterium spp. | bacterial infection | corynebacterium spp. | escherichia coli (e. coli) | mastitis | organisms sensitive to cloxacillin | staphylococcus spp. | streptococcus agalactiae | streptococcus spp. | abrasions | abscesses | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacterial infection | antiseptic | associated with viral disease | avian mycoplasmas | bacterial canker | blackhead | body odours | bowed tendons | broad spectrum | burns | clavulanic acid sensitive | coccidiosis | coliform complex | conjunctivitis | coryza | cowpox | cracks | crd | crusts | dandruff | dermatological disorders | dermatoses | dermatosis | diarrhoea | dry skin | dysentery | eczema | endometritis | enteric diseases | enteritis | enzootic pneumonia | escherichia coli | european brood disease | feed efficiency | fungal infections | gentamicin sensitive | girth galls | gram negative organisms | gram positive organisms | hypermotility | includin

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bell laboratories, inc. - zinc phosphide; malathion - ready-to-use bait - zinc phosphide ungrouped active 20.0 g/kg; malathion organophosphorus-dithiophospha other 0.11 g /kg - vertebrate poison

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - zinc chloride, quantity: 5.3 mg/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid - indications as at 01 jan 1991 : zinc chloride injection is intended for use as an additive to compatible intravenous fluids or total parenteral nutrition solutions. it is indicated for the prevention and treatment of zinc deficiency, which may be characterised by growth deterioration, skin lesions, alopecia, impaired reproductive development and function, and delayed or inhibited wound healing. indications as at 01 jan 1991 : zinc chloride injection is intended for use as an additive to compatible intravenous fluids or total parenteral nutrition solutions. it is indicated for the prevention and treatment of zinc deficiency, which may be characterised by growth deterioration, skin lesions, alopecia, impaired reproductive development and function, and delayed or inhibited wound healing.